Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.

Oncogene - 12 Apr 2007

Mangala L S, Fok J Y, Zorrilla-Calancha I R, Verma A, Mehta K

Abstract excerpt

Distant metastasis is frequently observed in patients with breast cancer and is a major cause of cancer-related deaths in these patients. Currently, very little is known about the mechanisms that underlie the development of the metastatic phenotype in breast cancer cells. We previously found that metastatic breast cancer cells express high levels of tissue transglutaminase (TG2), but established no direct link...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Survival
Share to Breast Neoplasms
Share to Cell Adhesion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to GTP-Binding Proteins

Share to Neoplasm Invasiveness

Share to Protein Glutamine gamma Glutamyltransferase 2

Share to Transglutaminases

Source

Identifiers

PMID: 17043648
DOI: 10.1038/sj.onc.1210035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.PMID 17043648Read ↗

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.Semantic proximity Read ↗

Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic nicheSemantic proximity Read ↗

Tissue transglutaminase: a new target to reverse cancer drug resistanceSemantic proximity Read ↗

Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.Semantic proximity Read ↗

Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.Semantic proximity Read ↗

Tissue transglutaminase: from biological glue to cell survival cues.Semantic proximity Read ↗

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy targetSemantic proximity Read ↗

The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour MicroenvironmentSemantic proximity Read ↗

The Role of Transglutaminase 2 in Cancer: An UpdateSemantic proximity Read ↗

The role of talin2 in breast cancer tumorigenesis and metastasisSemantic proximity Read ↗

The transglutaminase 2 gene is aberrantly hypermethylated in glioma.Semantic proximity Read ↗

Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.